0.68 - 0.75
0.33 - 0.86
18.36M / 4.66M (Avg.)
34.50 | 0.02
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
-3.84%
Negative revenue growth while 0819.HK stands at 35.91%. Joel Greenblatt would look for strategic missteps or cyclical reasons.
17.03%
Gross profit growth at 50-75% of 0819.HK's 25.64%. Martin Whitman would question if cost structure or brand is lagging.
39.17%
EBIT growth above 1.5x 0819.HK's 22.32%. David Dodd would confirm if core operations or niche positioning yield superior profitability.
39.17%
Operating income growth above 1.5x 0819.HK's 22.32%. David Dodd would confirm if consistent cost or pricing advantages drive this outperformance.
12.12%
Net income growth at 75-90% of 0819.HK's 15.50%. Bill Ackman would press for improvements to catch or surpass competitor performance.
13.73%
EPS growth at 75-90% of 0819.HK's 17.65%. Bill Ackman would push for improved profitability or share repurchases to catch up.
13.73%
Diluted EPS growth at 75-90% of 0819.HK's 17.65%. Bill Ackman would expect further improvements in net income or share count reduction.
-1.45%
Both firms reduce share counts. Martin Whitman would compare buyback intensity relative to free cash flow generation.
-1.36%
Both reduce diluted shares. Martin Whitman would review each firm’s ability to continue repurchases and manage option issuance.
-100.00%
Both companies cut dividends. Martin Whitman would look for a common factor, such as cyclical downturn or liquidity constraints.
-140.53%
Negative OCF growth while 0819.HK is at 67.52%. Joel Greenblatt would demand a turnaround plan focusing on real cash generation.
-128.18%
Negative FCF growth while 0819.HK is at 68.58%. Joel Greenblatt would demand improved cost control or more strategic capex discipline.
48403.57%
10Y revenue/share CAGR above 1.5x 0819.HK's 1846.25%. David Dodd would confirm if management’s strategic vision consistently outperforms the competitor.
21.62%
5Y revenue/share CAGR under 50% of 0819.HK's 327.52%. Michael Burry would suspect a significant competitive gap or product weakness.
2.09%
3Y revenue/share CAGR under 50% of 0819.HK's 54.09%. Michael Burry might see a serious short-term decline in relevance vs. the competitor.
-54872.48%
Negative 10Y OCF/share CAGR while 0819.HK stands at 2139.18%. Joel Greenblatt would scrutinize managerial effectiveness and product competitiveness.
-12824.71%
Negative 5Y OCF/share CAGR while 0819.HK is at 496.27%. Joel Greenblatt would question the firm’s operational model or cost structure.
-708.35%
Negative 3Y OCF/share CAGR while 0819.HK stands at 148.81%. Joel Greenblatt would demand an urgent turnaround in the firm’s cost or revenue drivers.
231.68%
Below 50% of 0819.HK's 596.95%. Michael Burry would worry about a sizable gap in long-term profitability gains vs. the competitor.
3699.57%
5Y net income/share CAGR above 1.5x 0819.HK's 40.34%. David Dodd would confirm if the firm’s strategy is more effective in generating mid-term profits.
574.70%
3Y net income/share CAGR 75-90% of 0819.HK's 745.34%. Bill Ackman might push for an operational plan to match or beat the competitor’s short-term growth.
No Data
No Data available this quarter, please select a different quarter.
96.16%
5Y equity/share CAGR above 1.5x 0819.HK's 47.68%. David Dodd might see stronger earnings retention or fewer asset impairments fueling growth.
39.07%
3Y equity/share CAGR above 1.5x 0819.HK's 25.79%. David Dodd verifies the company’s short-term capital management far exceeds the competitor’s pace.
No Data
No Data available this quarter, please select a different quarter.
-100.00%
Both lowered dividends mid-term. Martin Whitman might suspect broad sector constraints or strategic shifts from dividends.
No Data
No Data available this quarter, please select a different quarter.
-23.04%
Both reduce receivables yoy. Martin Whitman suspects a shift in the entire niche’s credit approach or softer demand.
15.68%
Inventory growth well above 0819.HK's 16.43%. Michael Burry suspects overshooting production or weaker sell-through vs. the competitor.
-13.03%
Negative asset growth while 0819.HK invests at 6.05%. Joel Greenblatt checks if the competitor might capture more market share unless our returns remain higher.
7.65%
50-75% of 0819.HK's 13.99%. Martin Whitman suspects weaker earnings or capital allocation vs. the competitor.
2122.61%
We have some new debt while 0819.HK reduces theirs. John Neff sees the competitor as more cautious unless our expansions pay off strongly.
-25.80%
Our R&D shrinks while 0819.HK invests at 52.62%. Joel Greenblatt checks if we risk falling behind a competitor’s new product pipeline.
25.32%
SG&A growth well above 0819.HK's 18.37%. Michael Burry sees potential margin erosion unless it translates into higher sales or brand equity.